Ye Ju Hua

Chrysanthemum indicum L.

Also known as: Wild chrysanthemum flower(English) 野菊花(Chinese)

Yeh Chü Hua

Updated October 29, 2026 · Not yet clinically reviewed

Ye Ju Hua
Photo: Pancrat, CC BY-SA 3.0, via Wikimedia Commons

Safety at a glance

Note

3 recorded drug interactions

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
clearing heat
Temperature
Cool
Taste
Bitter,Pungent
Channels
Liver,Heart

Functions

Clears Heat and Resolves Toxicity; Clears Heat and Reduces Swelling; Courses the Liver and Drains Heat; Disperses Wind-Heat

Traditional uses

Ye Ju Hua (wild chrysanthemum flower) is a bitter, cold herb considerably more potent than regular chrysanthemum (Ju Hua) in its ability to clear Heat toxin. It is a primary herb for carbuncles, furuncles, boils, and inflammatory skin abscesses from Heat toxin, as well as for throat infections, sore eyes, and Wind-Heat headache. Its stronger detoxifying action compared to garden chrysanthemum makes it preferred for acute infections and inflammatory conditions where a powerful Heat-clearing response is needed.

Western herbalism

Pharmacological effects

  • Anti-infectious: 1:5 decoction inhibited Shigella dysenteriae and other bacteria (MIC 1:80–1:10) and skin fungi; delayed cytopathic effects of ECHO11, herpes and influenza JK68-1 viruses in human embryonic cells; enhanced leukocyte phagocytosis at 1:1280.
  • Hypotensive: Ethanolic extracts lowered blood pressure in rats, cats and dogs (incl. renal hypertensive dogs) with slow onset and long duration, via adrenergic antagonism, peripheral vasodilation and possibly vasomotor-center inhibition.
  • Other cardiovascular: i.v. ethyl acetate extract (80 mg/kg) raised coronary flow 49.6% and renal blood flow 51.5% in dogs, reduced cardiac work and protected against ligation-induced ischemia; inhibited bacteria-induced platelet aggregation in vitro.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 217.

Formulas using this herb

7 of 7 formulas

Botanical

Chrysanthemum indicum, the wild or Indian chrysanthemum, is a perennial herb of the family Asteraceae, native to grassy slopes, roadsides, and forest margins across China, Korea, Japan, and parts of South and Southeast Asia. It grows 30 to 100 cm tall from short underground stolons, with erect, often branched stems bearing alternate, ovate, deeply pinnately lobed leaves with serrate margins that are softly grayish-pubescent beneath and aromatic when crushed. From late summer into autumn it produces numerous small composite flower heads 1 to 2.5 cm across, arranged in loose corymbose clusters; each head bears bright yellow ray florets surrounding a yellow disk, subtended by overlapping green involucral bracts. The flower heads are harvested at full bloom and dried for medicinal use, distinct from the larger, paler, cultivated heads of C. morifolium used as Ju Hua.

Family
Asteraceae
Pharmaceutical name
Chrysanthemi Indici Flos
Parts used
flower
Plant type
herb
Native region
Guangxi, Jiangsu, Shandong, Sichuan

Constituents

Linarin (buddleoside, acacetin-7-O-rutinoside)

Flavone glycoside · 0.001 to 3.284 percent of the dried flower head across 70 germplasms; only 41.4 percent of those germplasms reached the 0.8 percent required by the Chinese Pharmacopoeia

The pharmacopoeial marker for Chrysanthemi Indici Flos and the compound the drug is standardised on. A buddleoside-rich extract was hypotensive, hypoglycaemic and hypolipidaemic in diet-induced metabolic syndrome, rebalancing macrophage subpopulations and blocking NF-kappaB signalling. The nearly thousandfold spread in content across germplasms, and the fact that most fail the standard, is the single most practical fact about this herb: nominal gram doses are close to meaningless without a certificate of analysis. A white-flowered variant lacking linarin altogether has been characterised.

Luteolin

Flavone · 0.010 to 0.403 percent of the dried flower head across 70 germplasms

One of the two flavones consistently cited for the anti-inflammatory effect of this species. Content behaves unusually during drying, rising and then falling with a peak at around 40 percent water content, so origin processing changes the assay result as much as germplasm does.

Apigenin

Flavone · 0.003 to 0.152 percent of the dried flower head across 70 germplasms

Minor flavone aglycone of the flower head, contributing to the anti-inflammatory profile attributed to the drug.

Acacetin (4'-O-methylapigenin)

Flavone · 0 to 0.145 percent of the dried flower head across 70 germplasms; absent altogether in some

The aglycone of linarin. Its complete absence from some germplasms is a further reason to treat the species as chemically heterogeneous rather than a single defined drug.

Chlorogenic acid

Hydroxycinnamic acid ester (caffeoylquinic acid) · 0.052 to 0.815 percent of the dried flower head across 70 germplasms

Major phenylpropanoid of the flower head. It falls significantly with drying, so freshly dried material and long-stored material are not interchangeable on assay.

Isochlorogenic acid A (3,5-di-O-caffeoylquinic acid)

Dicaffeoylquinic acid · 0.007 to 1.888 percent of the dried flower head across 70 germplasms, with isochlorogenic acids B and C at 0.007 to 0.574 and 0.006 to 0.429 percent

Frequently the most abundant single phenylpropanoid in high-quality material. The phenylpropanoid content correlates positively with flower colour parameters, which is the empirical basis for the trade practice of judging quality of this drug by colour.

Camphor

Bicyclic monoterpene ketone · 36.69 percent of the essential oil of Chrysanthemum indicum, against 14.56 percent of the oil of Chrysanthemum morifolium

The clearest chemical line between Ye Ju Hua and Ju Hua. Camphor is the major constituent of both oils but is present at roughly two and a half times the proportion in C. indicum, and the C. indicum oil was the more biologically active in every assay in the head-to-head comparison. It is also the reason this herb is more pungent and more suited to topical and toxin-resolving use than the mild eye-and-Liver herb Ju Hua.

Drug interactions

Ju Hua (Chrysanthemum morifolium) supplied or substituted for Ye Ju Hua, and the reverse

Moderate · Two different official drugs with different chemistry, different potency and different standards; dose and safety data do not transfer between them · Evidence level: Established

Practitioners meet these two as near-identical yellow flower heads under near-identical pinyin, and the substitution is routine. The only head-to-head chemical and biological comparison analysed both oils by GC/FID and GC/MS: camphor is the major constituent of both but accounts for 36.69 percent of the C. indicum oil and 14.56 percent of the C. morifolium oil, and C. indicum was more active in every assay run, showing notable antitrypanosomal activity at IC50 45.89 micrograms/mL, antimicrobial activity against Streptococcus agalactiae at MIC 62.5 micrograms/mL, and inhibition of vesicular stomatitis virus replication at IC50 3.14 micrograms/mL, against antioxidant IC50 values of 2.21 mg/mL for C. indicum and 2.59 mg/mL for C. morifolium. Say which species a source used: the germplasm and drying studies quoted throughout this record are on C. indicum (Chrysanthemi Indici Flos), and Chrysanthemi Indici Flos is standardised on linarin at not less than 0.8 percent, a marker not used for Ju Hua.

Clinical note: Order and check by binomial, not by pinyin. Do not apply a Ju Hua monograph's dose, or its reputation for mildness, to Ye Ju Hua. If a formula calls for the Liver-and-eyes action, that is Ju Hua; the toxin-resolving and topical sore action is Ye Ju Hua.

Asteraceae (Compositae) cross-sensitisation: ragweed, mugwort, chamomile, feverfew, arnica, marigold, purple coneflower

Moderate · Contact dermatitis on topical use; oral allergy syndrome or systemic reaction on ingestion in a sensitised patient · Evidence level: Probable

Chrysanthemum indicum is an Asteraceae flower head, and this herb is used both internally and topically on inflamed skin, which is the highest-risk route. Asteraceae are established occupational sensitisers producing both immediate and delayed hypersensitivity. Two mechanisms operate: panallergens in Asteraceae pollen drive cross-reactivity that underlies pollen-food and pollen-medicine allergy syndrome, and sesquiterpene lactones sensitise on skin contact, with extensive cross-reactivity between them and the capacity to provoke systemic reactions on ingestion in an already sensitised person.

Clinical note: Ask specifically about hay fever to ragweed or mugwort and about reactions to chamomile tea or arnica cream before prescribing, and especially before any topical or compress application. Patch test rather than treat if the history is equivocal.

Antihypertensive and glucose-lowering drugs

Theoretical · Possible additive blood pressure and glucose lowering · Evidence level: Theoretical

A buddleoside-rich Chrysanthemum indicum extract had hypotensive, hypoglycaemic and hypolipidaemic effects in animal models of diet-induced metabolic syndrome. This is a concentrated extract in animals, not the crude flower head in humans, and no clinical pharmacodynamic study exists, so no magnitude can be attached.

Clinical note: No routine action. If the patient is on a tightly titrated antihypertensive, ask them to check blood pressure at home for a fortnight after starting a Ye Ju Hua containing formula.

Dosage

FormAmountFrequencyNotes
decoction9–15 gDaily
中国药典 2020 【用法与用量】9~15g。外用适量,煎汤外洗或制膏外涂。 【性味与归经】苦、辛,微寒。归肝、心经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Evidence

Study design on record, not certainty of outcome.

Randomized controlled trial
1
In vitro / animal
3

Efficacy and Safety of Ecklonia cava Kjellman Extract Complex in Respiratory Health: A Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Clinical Trial

Woo S, Lee SW, Kim J, Jung IC, Son JW, Lee B, Kwon SO, Byeon J, Park YC · Food Science & Nutrition · 2026 · RCT

Randomized controlled trial · Not yet verified

Read with care: this is a combination product, not a Chrysanthemum indicum monotherapy trial. 106 participants were randomised 1:1 to an Ecklonia cava extract complex containing C. indicum extract, or placebo, twice daily for 12 weeks. The breathlessness, cough and sputum scale total and its breathlessness and sputum components, FEV1, and cough and sputum visual analogue scores improved significantly against placebo; the St George's respiratory questionnaire and the modified MRC dyspnoea scale did not differ. No severe adverse events occurred. The contribution of C. indicum specifically cannot be separated from that of the seaweed extract, and the authors themselves attribute the result to the established pharmacology of Ecklonia cava.

doi:10.1002/fsn3.71449

Chrysanthemum indicum and Chrysanthemum morifolium: Chemical Composition of Their Essential Oils and Their Potential Use as Natural Preservatives with Antimicrobial and Antioxidant Activities

Youssef FS, Eid SY, Alshammari E, Ashour ML, Wink M, El-Readi MZ · Foods · 2020 · in vitro

In vitro / animal · Not yet verified

The species-discrimination study for this record. Essential oils of Chrysanthemum indicum and C. morifolium were compared by GC/FID and GC/MS and tested side by side. Camphor was the major constituent of both, at 36.69 percent in C. indicum and 14.56 percent in C. morifolium. C. indicum was biologically more active in every experiment: antitrypanosomal IC50 45.89 micrograms/mL, MIC 62.5 micrograms/mL against Streptococcus agalactiae, and inhibition of vesicular stomatitis virus replication at IC50 3.14 micrograms/mL, with both oils antioxidant at IC50 2.21 mg/mL (C. indicum) and 2.59 mg/mL (C. morifolium).

doi:10.3390/foods9101460

Buddleoside-rich Chrysanthemum indicum L. extract modulates macrophage-mediated inflammation to prevent metabolic syndrome induced by unhealthy diet

Zhou Y, Su J, Dong Y, He Z, Wang Y, Chen S, Lv G · BMC Complementary Medicine and Therapies · 2024 · animal

In vitro / animal · Verified

A buddleoside-rich Chrysanthemum indicum extract was tested for prevention of diet-induced metabolic syndrome. It was hypotensive, hypoglycaemic and hypolipidaemic, corrected the imbalance between macrophage subpopulations, blocked NF-kappaB signalling, reduced inflammatory mediator secretion, improved insulin resistance and protected liver and pancreas from inflammatory damage, with the mechanism confirmed in an LPS-induced macrophage model.

doi:10.1186/s12906-024-04583-2

Effect of different drying degrees on content of various chemical components and in vitro bioactivity of Chrysanthemi Indici Flos

Wang T, Dong S, Guo Q, Zou Q, Yang F · Chinese Herbal Medicines · 2025 · in vitro

In vitro / animal · Not yet verified

Processing study, describing how the crude drug changes as it is dried rather than the raw flower alone. Fresh flower heads were dried at 60 degrees Celsius to a series of water contents. Chlorogenic acid and linarin fell significantly with drying; luteolin and kaempferol rose then fell, peaking at 40 percent water content; naringenin was highest at 80 percent water content. HPLC fingerprint similarity between the wettest and fully dried samples was only 0.559. Antioxidant and anti-inflammatory activity in vitro strengthened with drying. Extracts inhibited Staphylococcus aureus at MIC 1.560 to 3.125 mg/mL and Escherichia coli at MIC 3.125 mg/mL, but not Pseudomonas aeruginosa or Salmonella paratyphoid.

doi:10.1016/j.chmed.2025.08.001

Safety

Contraindications

Its use is cautious in pregnant women and patients with deficiency-cold of the spleen and stomach.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 53–72.

Side effects

  • A few patients had gastric discomfort, poor appetite, borborygmus and loose stools after decoction or ethanolic extract

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 217.

Cultural and historical

Ben Cao Jing Ji Zhu (Collected Commentaries on the Classic of Materia Medica), Tao Hongjing · Southern and Northern dynasties, circa 500 CE

Records the bitter wild chrysanthemum under the name ku yi and distinguishes it from the sweet cultivated ju hua, warning against confusing the two. The classical tradition therefore separates Ye Ju Hua from Ju Hua from the outset, which is the same distinction the modern binomials Chrysanthemum indicum and C. morifolium preserve.

Ben Cao Gang Mu (Compendium of Materia Medica), Li Shizhen · Ming dynasty, 1596

Li Shizhen gives wild chrysanthemum its own independent entry rather than treating it as an inferior grade of ju hua, formalising it as a separate drug of the toxin-resolving type.

References

  1. Li J, Ye Z, Wei M, Deng C, Chi L, Xu L, Han Z, Wei W. Evaluation of Chrysanthemi Indici Flos germplasms based on nine bioactive constituents and color parameters. PLOS ONE. 2023 doi:10.1371/journal.pone.0283498
  2. Ključevšek T, Kreft S. Allergic Potential of Medicinal Plants From the Asteraceae Family. Health Science Reports. 2025 doi:10.1002/hsr2.70398
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice